9/30/2023 | 38229090 | EP-Y0001695-IMATINIB IMPURITY A CRS - (0.03MG)-(PHARMACEUTICAL REFERENCE STANDARD) | XXXXXXXXXX | 3 | NOS | 259.77 | FRANCE | STRASBOURG |
9/30/2023 | 38229090 | EP-Y0002048-EVEROLIMUS CRS-(70MG)-(PHARMACEUTICAL REFERENCESTANDARD) | XXXXXXXXXX | 2 | NOS | 657.65 | FRANCE | STRASBOURG |
9/29/2023 | 38229090 | EP-Y0000284_FLUTICASONE PROPIONATE (80 MG)-(PHARMACEUTICAL REFERENCE STANDARD) | XXXXXXXXXX | 2 | NOS | 176.34 | FRANCE | STRASBOURG |
9/29/2023 | 38229090 | EP-Y0002167_ROSUVASTATIN IMPURITY MIXTURE (0.002 MG)-(PHARMACEUTICAL REFERENCE STANDARD) | XXXXXXXXXX | 3 | NOS | 264.5 | FRANCE | STRASBOURG |
9/29/2023 | 38229090 | EP-Y0000641_AZITHROMYCIN FOR SYSTEM SUITABILITY (0.1 MG)-(PHARMACEUTICAL REFERENCE STANDARD) | XXXXXXXXXX | 4 | NOS | 352.67 | FRANCE | STRASBOURG |
9/29/2023 | 38229090 | EP-D0720000_DEXAMETHASONE SODIUM PHOSPHATE (130 MG)-(PHARMACEUTICAL REFERENCE STANDARD) | XXXXXXXXXX | 5 | NOS | 440.84 | FRANCE | STRASBOURG |
9/29/2023 | 38229090 | EP-M1556000_METHYL 12-HYDROXYSTEARATE (110 MG)-(PHARMACEUTICAL REFERENCE STANDARD) | XXXXXXXXXX | 5 | NOS | 440.84 | FRANCE | STRASBOURG |
9/29/2023 | 38229090 | EP-Y0001816_SODIUM AMINOSALICYLATE DIHYDRATE FOR EQUIPMENT QUALIFICATION (5000 MG)-(PHARMACEUTICAL REFERENCE STANDARD) | XXXXXXXXXX | 2 | NOS | 176.34 | FRANCE | STRASBOURG |
9/29/2023 | 38229090 | EP-Y0000664_METHOTREXATE IMPURITY E (10 MG)-(PHARMACEUTICALREFERENCE STANDARD) | XXXXXXXXXX | 2 | NOS | 176.34 | FRANCE | STRASBOURG |
9/29/2023 | 38229090 | EP-Y0000695_NALOXONE FOR PEAK IDENTIFICATION (5.1 MG)-(PHARMACEUTICAL REFERENCE STANDARD) | XXXXXXXXXX | 3 | NOS | 264.5 | FRANCE | STRASBOURG |